Patterns of Prescription Drug Use Before and After Fragility Fracture.

PubWeight™: 0.81‹?›

🔗 View Article (PMID 27548843)

Published in JAMA Intern Med on October 01, 2016

Authors

Jeffrey C Munson1, Julie P W Bynum1, John-Erik Bell2, Robert Cantu3, Christine McDonough4, Qianfei Wang5, Tor D Tosteson6, Anna N A Tosteson1

Author Affiliations

1: The Dartmouth Institute for Health Policy and Clinical Practice, Geisel School of Medicine at Dartmouth, Lebanon, New Hampshire2Department of Medicine, Geisel School of Medicine at Dartmouth, Lebanon, New Hampshire.
2: The Dartmouth Institute for Health Policy and Clinical Practice, Geisel School of Medicine at Dartmouth, Lebanon, New Hampshire3Department of Orthopaedics, Dartmouth-Hitchcock Medical Center, Lebanon, New Hampshire.
3: Department of Orthopaedics, Dartmouth-Hitchcock Medical Center, Lebanon, New Hampshire.
4: Boston University School of Public Health, Boston, Massachusetts.
5: The Dartmouth Institute for Health Policy and Clinical Practice, Geisel School of Medicine at Dartmouth, Lebanon, New Hampshire.
6: The Dartmouth Institute for Health Policy and Clinical Practice, Geisel School of Medicine at Dartmouth, Lebanon, New Hampshire5Department of Biomedical Data Science, Geisel School of Medicine at Dartmouth, Lebanon, New Hampshire.

Articles cited by this

Incidence and economic burden of osteoporosis-related fractures in the United States, 2005-2025. J Bone Miner Res (2007) 14.84

Long-term proton pump inhibitor therapy and risk of hip fracture. JAMA (2006) 9.53

Psychotropic drug use and the risk of hip fracture. N Engl J Med (1987) 7.53

Meta-analysis of the impact of 9 medication classes on falls in elderly persons. Arch Intern Med (2009) 5.36

A meta-analysis of previous fracture and subsequent fracture risk. Bone (2004) 4.92

Medical expenditures for the treatment of osteoporotic fractures in the United States in 1995: report from the National Osteoporosis Foundation. J Bone Miner Res (1997) 4.74

Effect of selective serotonin reuptake inhibitors on the risk of fracture. Arch Intern Med (2007) 4.68

Drugs and falls in older people: a systematic review and meta-analysis: I. Psychotropic drugs. J Am Geriatr Soc (1999) 4.35

Rosiglitazone-associated fractures in type 2 diabetes: an Analysis from A Diabetes Outcome Progression Trial (ADOPT). Diabetes Care (2008) 3.45

Alendronate for the primary and secondary prevention of osteoporotic fractures in postmenopausal women. Cochrane Database Syst Rev (2008) 3.45

Central nervous system-active medications and risk for falls in older women. J Am Geriatr Soc (2002) 3.03

Rates of Deintensification of Blood Pressure and Glycemic Medication Treatment Based on Levels of Control and Life Expectancy in Older Patients With Diabetes Mellitus. JAMA Intern Med (2015) 2.87

Fragility fractures and the osteoporosis care gap: an international phenomenon. Semin Arthritis Rheum (2006) 2.73

Practice patterns in the diagnosis and treatment of osteoporosis after a fragility fracture: a systematic review. Osteoporos Int (2004) 2.62

Oral corticosteroids and fracture risk: relationship to daily and cumulative doses. Rheumatology (Oxford) (2000) 2.13

Quality of osteoporosis care of older Medicare recipients with fragility fractures: 2006 to 2010. J Am Geriatr Soc (2013) 2.08

The risk of nonvertebral fracture related to inhaled corticosteroid exposure among adults with chronic respiratory disease. Chest (2005) 2.04

Risedronate for the primary and secondary prevention of osteoporotic fractures in postmenopausal women. Cochrane Database Syst Rev (2008) 2.00

Thiazolidinediones and fractures in men and women. Arch Intern Med (2009) 1.98

The contribution of hip fracture to risk of subsequent fractures: data from two longitudinal studies. Osteoporos Int (2003) 1.97

Hip fracture patients at risk of second hip fracture: a nationwide population-based cohort study of 169,145 cases during 1977-2001. J Bone Miner Res (2009) 1.76

Second hip fracture in older men and women: the Framingham Study. Arch Intern Med (2007) 1.72

Fracture risk associated with inhaled corticosteroid use in chronic obstructive pulmonary disease. Am J Respir Crit Care Med (2004) 1.68

Association between SSRI use and hip fractures and the effect of residual confounding bias in claims database studies. J Clin Psychopharmacol (2004) 1.68

Fracture risk with intermittent high-dose oral glucocorticoid therapy. Arthritis Rheum (2007) 1.63

Underuse of osteoporosis medications in elderly patients with fractures. Am J Med (2003) 1.57

Etidronate for the primary and secondary prevention of osteoporotic fractures in postmenopausal women. Cochrane Database Syst Rev (2008) 1.46

Psychotropic medications and the risk of fracture: a meta-analysis. Drug Saf (2007) 1.41

Anxiolytics, sedatives, antidepressants, neuroleptics and the risk of fracture. Osteoporos Int (2006) 1.39

Opioid analgesics and the risk of hip fracture in the elderly: codeine and propoxyphene. J Gerontol (1992) 1.36

Radial and humeral fractures as predictors of subsequent hip, radial or humeral fractures in women, and their seasonal variation. Osteoporos Int (1993) 1.22

Occurrence and incidence of the second hip fracture. Clin Orthop Relat Res (1993) 1.22

Cognitive impairment, drug use, and the risk of hip fracture in persons over 75 years old: a community-based prospective study. Am J Epidemiol (1998) 1.18

Benzodiazepines and the risk of falls in nursing home residents. J Am Geriatr Soc (2000) 1.17

Use of inhaled corticosteroids and the risk of fracture. Chest (2006) 1.16

Outcomes and secondary prevention strategies for male hip fractures. Ann Pharmacother (2002) 0.97

Factors associated with a second hip fracture: a systematic review. Clin Rehabil (2007) 0.96

Treatment with fall-risk-increasing and fracture-preventing drugs before and after a hip fracture: an observational study. Drugs Aging (2010) 0.96

Subsequent hip fracture among older adults. Am J Public Health (1994) 0.95

Risk of hip/femur fractures in patients using antipsychotics. Bone (2005) 0.90

Second fractures among older adults in the year following hip, shoulder, or wrist fracture. Osteoporos Int (2016) 0.83

Development of the Tool to Reduce Inappropriate Medications (TRIM): A Clinical Decision Support System to Improve Medication Prescribing for Older Adults. Pharmacotherapy (2016) 0.80

Forecasting the burden of future postmenopausal hip fractures. Osteoporos Int (2014) 0.79

Electronic surveillance and pharmacist intervention for vulnerable older inpatients on high-risk medication regimens. J Am Geriatr Soc (2014) 0.77